Share Email Print
cover

Proceedings Paper

Photodynamic therapy (PDT) using intratumoral injection of the 5- aminolevulinic acid (5-ALA) for the treatment of eye cancer in cattle
Author(s): Raduan Hage; Geraldo Mancilha; Renato Amaro Zângaro; Egberto Munin; Hélio Plapler
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

A six-year old Holstein cow with an eye cancer (ocular squamous cell carcinoma) involving the third eyelid and conjunctiva was submitted to photodynamic therapy using intratumoral 20% aminolevulinic acid (5-ALA - Aldrich Chemical Company, Milwaukee, USA) and a light emitting diode (LED - VET LED - MMOptics(R)) with wavelength between 600 and 700 nm, 2 cm diameter circular light beam, power of 150 mW, light dose of 50 J/cm2 as a source of irradiation. Fifteen days after the experimental procedure we observed about 50% tumor reduction and complete remission after 3 months. Relapse was not observed up to 12 months after the treatment. Although the study only includes one animal not allowing definite conclusions, it indicates that PDT represents a safe and technically feasible approach in the treatment of eye cancer in cattle.

Paper Details

Date Published: 28 February 2007
PDF: 7 pages
Proc. SPIE 6427, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVI, 64271C (28 February 2007); doi: 10.1117/12.701316
Show Author Affiliations
Raduan Hage, Univ. Federal de São Paulo (Brazil)
Univ. do Vale do Paraíba (Brazil)
Geraldo Mancilha, Univ. do Vale do Paraíba (Brazil)
Renato Amaro Zângaro, Univ. do Vale do Paraíba (Brazil)
Egberto Munin, Univ. do Vale do Paraíba (Brazil)
Hélio Plapler, Univ. Federal de São Paulo (Brazil)


Published in SPIE Proceedings Vol. 6427:
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVI
David Kessel, Editor(s)

© SPIE. Terms of Use
Back to Top